Abstract
Cellular DNA was analysed by flow cytometry in fine needles aspirates (FNA) from both benign and malignant breast lesions in order to determine the feasibility of flow cytometric analysis. In 22 of 26 (84%) benign and 69 of 74 (93%) malignant aspirates, sufficient cells were present to produce good quality DNA histograms. DNA in all 22 benign lesions was diploid. In contrast, of the 69 cancers with sufficient cells for analysis, 40.6% had a diploid DNA content alone, whilst 59.4% had an additional DNA aneuploid line. These results indicate that the majority of FNAs provide sufficient material for flow cytometric analysis of DNA profiles. Such aspirates taken in a sequential manner may also prove to be an ideal method of studying tumour response to therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levack, P., Mullen, P., Anderson, T. et al. DNA analysis of breast tumour fine needle aspirates using flow cytometry. Br J Cancer 56, 643–646 (1987). https://doi.org/10.1038/bjc.1987.259
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.259
This article is cited by
-
Quantitative morphometric analysis of fine needle aspirates of breast carcinoma
Breast Cancer (2001)
-
Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer
Breast Cancer Research and Treatment (1994)
-
Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies
Breast Cancer Research and Treatment (1991)
